**Core Concept:**
Herpes simplex virus (HSV) is a common cause of viral keratitis, which is an inflammation of the cornea. HSV infection can lead to severe pain, vision impairment, and even blindness if left untreated. Herpes simplex virus types 1 and 2 are responsible for ocular herpes, with HSV-1 causing ocular herpes more frequently.

**Why the Correct Answer is Right:**
The correct answer is "Acyclovir" (ACV). Acyclovir is a nucleoside analogue antiviral drug that inhibits viral DNA synthesis by competing with the natural substrate, deoxyguanosine monophosphate (dGMP), for incorporation into the viral DNA. HSV has a reduced enzyme thymidine kinase, which is involved in the activation of ACV. ACV is activated to acyclovir triphosphate (ACV-TP) and inhibits HSV DNA polymerase, thereby preventing viral DNA replication and reducing the severity of the infection.

**Why Each Wrong Option is Incorrect:**

**Option B:** Famciclovir (FCV) is another antiviral drug that is used for herpes simplex virus infection but is significantly less potent than ACV. It is also not as well-tolerated.

**Option C:** Valacyclovir (VVC) is a prodrug of ACV, which is converted to ACV by the liver enzyme L-valine transaminase. VVC is not as potent or effective as ACV in treating ocular herpes.

**Option D:** Idoxuridine (IDU) is an old antiviral drug used for ocular herpes but has been largely replaced by ACV due to its lower efficacy, higher toxicity, and more significant side effects.

**Clinical Pearl:**
Herpes simplex virus-induced keratitis is a clinical condition that requires prompt initiation of antiviral therapy to prevent vision loss. ACV is the drug of choice due to its high potency and fewer side effects compared to other antiviral drugs.

**Correct Answer Explanation:**
Acyclovir (ACV) is the drug of choice for treating ocular herpes simplex virus infection. The correct answer is ACV because it has a higher potency and efficacy in treating ocular herpes compared to other antiviral drugs like famciclovir (FCV), valacyclovir (VVC), and idoxuridine (IDU). ACV is activated to its active form, acyclovir triphosphate, which inhibits HSV DNA polymerase, thus preventing viral DNA replication and reducing the severity of the ocular herpes infection.